167 related articles for article (PubMed ID: 34965300)
1. A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation.
Sabarwal A; Wedel J; Liu K; Zurakowski D; Chakraborty S; Flynn E; Briscoe DM; Balan M; Pal S
Carcinogenesis; 2022 May; 43(4):360-370. PubMed ID: 34965300
[TBL] [Abstract][Full Text] [Related]
2. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
Balan M; Chakraborty S; Flynn E; Zurakowski D; Pal S
Sci Rep; 2017 Jul; 7(1):5900. PubMed ID: 28724911
[TBL] [Abstract][Full Text] [Related]
3. Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules.
Banerjee P; Basu A; Wegiel B; Otterbein LE; Mizumura K; Gasser M; Waaga-Gasser AM; Choi AM; Pal S
J Biol Chem; 2012 Sep; 287(38):32113-23. PubMed ID: 22843690
[TBL] [Abstract][Full Text] [Related]
4. Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53/PI3K/Akt/mTOR signaling pathway.
Lin CJ; Chen TL; Tseng YY; Wu GJ; Hsieh MH; Lin YW; Chen RM
Toxicol Appl Pharmacol; 2016 Aug; 304():59-69. PubMed ID: 27236003
[TBL] [Abstract][Full Text] [Related]
5. A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress.
Rawat L; Balan M; Sasamoto Y; Sabarwal A; Pal S
Redox Biol; 2023 Dec; 68():102945. PubMed ID: 37898101
[TBL] [Abstract][Full Text] [Related]
6. A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape.
Sabarwal A; Chakraborty S; Mahanta S; Banerjee S; Balan M; Pal S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635337
[TBL] [Abstract][Full Text] [Related]
7. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
8. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
Yeh PS; Wang W; Chang YA; Lin CJ; Wang JJ; Chen RM
Cancer Lett; 2016 Jan; 370(1):66-77. PubMed ID: 26454217
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression.
Basu A; Liu T; Banerjee P; Flynn E; Zurakowski D; Datta D; Viklicky O; Gasser M; Waaga-Gasser AM; Yang J; Pal S
Cancer Lett; 2012 Aug; 321(2):179-86. PubMed ID: 22343319
[TBL] [Abstract][Full Text] [Related]
10. The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.
Banerjee P; Basu A; Arbiser JL; Pal S
Cancer Lett; 2013 Sep; 338(2):292-9. PubMed ID: 23752066
[TBL] [Abstract][Full Text] [Related]
11. Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation.
Liu X; Gu Y; Bian Y; Cai D; Li Y; Zhao Y; Zhang Z; Xue M; Zhang L
Apoptosis; 2021 Apr; 26(3-4):195-208. PubMed ID: 33550458
[TBL] [Abstract][Full Text] [Related]
12. Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.
Lv X; Liu F; Shang Y; Chen SZ
Oncol Rep; 2015 Sep; 34(3):1289-300. PubMed ID: 26136140
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.
Cirstea D; Hideshima T; Rodig S; Santo L; Pozzi S; Vallet S; Ikeda H; Perrone G; Gorgun G; Patel K; Desai N; Sportelli P; Kapoor S; Vali S; Mukherjee S; Munshi NC; Anderson KC; Raje N
Mol Cancer Ther; 2010 Apr; 9(4):963-75. PubMed ID: 20371718
[TBL] [Abstract][Full Text] [Related]
14. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Li H; Jin X; Zhang Z; Xing Y; Kong X
Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
[TBL] [Abstract][Full Text] [Related]
16. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.
Hahm ER; Sakao K; Singh SV
Prostate; 2014 Sep; 74(12):1209-21. PubMed ID: 25043291
[TBL] [Abstract][Full Text] [Related]
17. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling pathway is inhibited downstream of the cyclophilin D-mediated mitochondrial permeability transition in honokiol-triggered regulated necrosis.
Tian W; Xiong J; Zhu S; Xu D; Shen H; Deng Y
Mol Med Rep; 2016 Apr; 13(4):3227-35. PubMed ID: 26936128
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of rapamycin in pancreatic cancer cells by inducing apoptosis and autophagy.
Dai ZJ; Gao J; Ma XB; Kang HF; Wang BF; Lu WF; Lin S; Wang XJ; Wu WY
Int J Mol Sci; 2012 Dec; 14(1):273-85. PubMed ID: 23344033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
